For each patient, HOXD10 and HOXD11 but not HOXB2 mRNA expression was gradually elevated in LM, PCA and N tissues, indicating the oncogenic potential of tumor aggressiveness in PSCC (Fig. 1C and Fig. S1). This evidence concerns the gene HOXB2 and neoplasm.